Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Implementation of a New Hepatic Artery Infusion Program for Colorectal Liver Metastases is Safe, Feasible, and Effective

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. D'Angelica MI, Correa-Gallego C, Paty PB, et al. Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes. Ann Surg 2015;261(2):353-60.

    Article  Google Scholar 

  2. Kemeny NE, Niedzwiecki D, Hollis DR, et al. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 2006;24(9):1395-403.

    Article  CAS  Google Scholar 

  3. Cercek A, Boucher TM, Gluskin JS, et al. Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies. J Surg Oncol 2016;114(6):655-663.

    Article  CAS  Google Scholar 

  4. Allen PJ, Nissan A, Picon AI, et al. Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. J Am Coll Surg 2005;201(1):57-65.

    Article  Google Scholar 

  5. Creasy JM, Napier KJ, Reed SA, et al. Implementation of a hepatic artery infusion program: initial patient selection and perioperative outcomes of concurrent HAI and systemic chemotherapy for colorectal liver metastases. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08972-y.

Download references

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, Department of Surgery, Duke University Medical Center, Durham, NC, USA

    John M. Creasy MD & Michael E. Lidsky MD

Authors
  1. John M. Creasy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael E. Lidsky MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael E. Lidsky MD.

Ethics declarations

Disclosure

John M. Creasy and Michael E. Lidsky declare no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Creasy, J.M., Lidsky, M.E. ASO Author Reflections: Implementation of a New Hepatic Artery Infusion Program for Colorectal Liver Metastases is Safe, Feasible, and Effective. Ann Surg Oncol 27, 5096–5097 (2020). https://doi.org/10.1245/s10434-020-09040-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-09040-1

Search

Navigation